![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 20, 17163-17171, May 18, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Center for Immunotherapy of Cancer and Infectious
Diseases, University of Connecticut School of Medicine, Farmington,
Connecticut 06030
The studies reported here bear on the events in
the cytosol that lead to trafficking of peptides during antigen
processing and presentation by major histocompatibility complex (MHC) I
molecules. We have introduced free antigenic peptides or antigenic
peptides bound to serum albumin or to cytosolic heat shock proteins
hsp90 (and its endoplasmic reticular homologue gp96) or hsp70 into the cytosol of living cells and have monitored the presentation of the
peptides by appropriate MHC I molecules. The experiments show that (i)
free peptides or serum albumin-bound peptides, introduced into the
cytosol, become ligands of MHC I molecules at a far lower efficiency
than peptides chaperoned by any of the heat shock proteins tested and
(ii) treatment of cells with deoxyspergualin, a drug that binds hsp70
and hsp90 with apparent specificity, abrogates the ability of cells to
present antigenic peptides through MHC I molecules, and introduction of
additional hsp70 into the cytosol overcomes this abrogation. These
results suggest for the first time a functional role for cytosolic
chaperones in antigen processing.
Heat Shock Protein-chaperoned Peptides but Not Free Peptides
Introduced into the Cytosol Are Presented Efficiently by Major
Histocompatibility Complex I Molecules*
,
§, and
*
This work was supported by National Institutes of Health
Grants CA64394 and CA44786, Defense Advanced Research Project
Agency Grant BAA96024, and a research agreement with Antigenics,
Inc, in which company one of us (P. K. S.) has a significant
financial interest.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
Present address: Memorial Sloan-Kettering Cancer Center, New York,
NY 10021.
¶
To whom correspondence should be addressed: School of
Medicine, MC1601, University of Connecticut, Farmington, CT 06030-1920. Tel.: 860-679-4444; Fax: 860-679-4365; E-mail:
srivastava@nso2.uchc.edu.
This article has been cited by other articles:
![]() |
A. De Filippo, R. J. Binder, C. Camisaschi, V. Beretta, F. Arienti, A. Villa, P. Della Mina, G. Parmiani, L. Rivoltini, and C. Castelli Human Plasmacytoid Dendritic Cells Interact with gp96 via CD91 and Regulate Inflammatory Responses J. Immunol., November 1, 2008; 181(9): 6525 - 6535. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamano, S. Mizukami, S. Murata, T. Chiba, K. Tanaka, and H. Udono Hsp90-mediated Assembly of the 26 S Proteasome Is Involved in Major Histocompatibility Complex Class I Antigen Processing J. Biol. Chem., October 17, 2008; 283(42): 28060 - 28065. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Callahan, M. Garg, and P. K. Srivastava Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation PNAS, February 5, 2008; 105(5): 1662 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Binder, J. B. Kelly III, R. E. Vatner, and P. K. Srivastava Specific Immunogenicity of Heat Shock Protein gp96 Derives from Chaperoned Antigenic Peptides and Not from Contaminating Proteins J. Immunol., December 1, 2007; 179(11): 7254 - 7261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bendz, S. C. Ruhland, M. J. Pandya, O. Hainzl, S. Riegelsberger, C. Brauchle, M. P. Mayer, J. Buchner, R. D. Issels, and E. Noessner Human Heat Shock Protein 70 Enhances Tumor Antigen Presentation through Complex Formation and Intracellular Antigen Delivery without Innate Immune Signaling J. Biol. Chem., October 26, 2007; 282(43): 31688 - 31702. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurotaki, Y. Tamura, G. Ueda, J. Oura, G. Kutomi, Y. Hirohashi, H. Sahara, T. Torigoe, H. Hiratsuka, H. Sunakawa, et al. Efficient Cross-Presentation by Heat Shock Protein 90-Peptide Complex-Loaded Dendritic Cells via an Endosomal Pathway J. Immunol., August 1, 2007; 179(3): 1803 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Kislin, M. T. Marron, G. Li, M. W. Graner, and E. Katsanis Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia FASEB J, July 1, 2007; 21(9): 2173 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bae, C. Mitsiades, Y.-T. Tai, R. Bertheau, M. Shammas, R. B. Batchu, C. Li, L. Catley, R. Prabhala, K. C. Anderson, et al. Phenotypic and Functional Effects of Heat Shock Protein 90 Inhibition on Dendritic Cell J. Immunol., June 15, 2007; 178(12): 7730 - 7737. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy J. Leukoc. Biol., January 1, 2007; 81(1): 15 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Galazka, M. Stasiolek, A. Walczak, A. Jurewicz, A. Zylicz, C. F. Brosnan, C. S. Raine, and K. W. Selmaj Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis J. Immunol., February 1, 2006; 176(3): 1588 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Clayton, A. Turkes, H. Navabi, M. D. Mason, and Z. Tabi Induction of heat shock proteins in B-cell exosomes J. Cell Sci., August 15, 2005; 118(16): 3631 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zeng, M. W. Graner, S. Thompson, M. Marron, and E. Katsanis Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells Blood, March 1, 2005; 105(5): 2016 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, M. Zhou, J. Han, X. Zhu, T. Dong, G. F. Gao, and P. Tien Generation of Murine CTL by a Hepatitis B Virus-Specific Peptide and Evaluation of the Adjuvant Effect of Heat Shock Protein Glycoprotein 96 and Its Terminal Fragments J. Immunol., January 1, 2005; 174(1): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lewis Therapeutic cancer vaccines: Using unique antigens PNAS, October 5, 2004; 101(suppl_2): 14653 - 14656. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ren, R. Strube, X. Zhang, S.-Y. Chen, and X. F. Huang Potent Tumor-Specific Immunity Induced by an In vivo Heat Shock Protein-Suicide Gene-Based Tumor Vaccine Cancer Res., September 15, 2004; 64(18): 6645 - 6651. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. M. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, et al. Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells Clin. Cancer Res., July 1, 2004; 10(13): 4498 - 4508. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. R. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding Bacterial Heat Shock Proteins Promote CD91-Dependent Class I MHC Cross-Presentation of Chaperoned Peptide to CD8+ T Cells by Cytosolic Mechanisms in Dendritic Cells versus Vacuolar Mechanisms in Macrophages J. Immunol., May 1, 2004; 172(9): 5277 - 5286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Martin, D. Nolan, S. Gaudieri, C. A. Almeida, R. Nolan, I. James, F. Carvalho, E. Phillips, F. T. Christiansen, A. W. Purcell, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant PNAS, March 23, 2004; 101(12): 4180 - 4185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stebbing, P. Savage, S. Patterson, and B. Gazzard All for CD91 and CD91 for all J. Antimicrob. Chemother., January 1, 2004; 53(1): 1 - 3. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Mycko, H. Cwiklinska, J. Szymanski, B. Szymanska, G. Kudla, L. Kilianek, A. Odyniec, C. F. Brosnan, and K. W. Selmaj Inducible Heat Shock Protein 70 Promotes Myelin Autoantigen Presentation by the HLA Class II J. Immunol., January 1, 2004; 172(1): 202 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. F. Huang, W. Ren, L. Rollins, P. Pittman, M. Shah, L. Shen, Q. Gu, R. Strube, F. Hu, and S.-Y. Chen A Broadly Applicable, Personalized Heat Shock Protein-Mediated Oncolytic Tumor Vaccine Cancer Res., November 1, 2003; 63(21): 7321 - 7329. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Bland, M. K. Lemberg, A. J. McMichael, B. Martoglio, and V. M. Braud Requirement of the Proteasome for the Trimming of Signal Peptide-derived Epitopes Presented by the Nonclassical Major Histocompatibility Complex Class I Molecule HLA-E J. Biol. Chem., September 5, 2003; 278(36): 33747 - 33752. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dangles-Marie, S. Richon, M. El Behi, H. Echchakir, G. Dorothee, J. Thiery, P. Validire, I. Vergnon, J. Menez, M. Ladjimi, et al. A Three-Dimensional Tumor Cell Defect in Activating Autologous CTLs Is Associated with Inefficient Antigen Presentation Correlated with Heat Shock Protein-70 Down-Regulation Cancer Res., July 1, 2003; 63(13): 3682 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zeng, H. Feng, M. W. Graner, and E. Katsanis Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity Blood, June 1, 2003; 101(11): 4485 - 4491. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Miura, K. Morris, S. Ryan, J. L. Cook, and J. M. Routes Adenovirus E1A, Not Human Papillomavirus E7, Sensitizes Tumor Cells to Lysis by Macrophages Through Nitric Oxide- and TNF-{alpha}-Dependent Mechanisms Despite Up-Regulation of 70-kDa Heat Shock Protein J. Immunol., April 15, 2003; 170(8): 4119 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Noessner, R. Gastpar, V. Milani, A. Brandl, P. J. S. Hutzler, M. C. Kuppner, M. Roos, E. Kremmer, A. Asea, S. K. Calderwood, et al. Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells J. Immunol., November 15, 2002; 169(10): 5424 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Callahan, D. Chaillot, C. Jacquin, P. R. Clark, and A. Menoret Differential Acquisition of Antigenic Peptides by Hsp70 and Hsc70 under Oxidative Conditions J. Biol. Chem., September 6, 2002; 277(37): 33604 - 33609. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamano, S. Murata, N. Shimbara, N. Tanaka, T. Chiba, K. Tanaka, K. Yui, and H. Udono Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing J. Exp. Med., July 15, 2002; 196(2): 185 - 196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |